Subba R. Chintalacharuvu, PhD, MBA
An innovative, people oriented and results-driven technical leader with over 16 years of experience in R & D in the Eli Lilly & Company and Covance. Successfully managed high-performance R & D teams and supervised multiple cross-functional teams to deliver candidates for autoimmune diseases, NASH and diabetic nephropathy. Developed expertise in analyzing respective market sizes, uncovering unmet medical needs, adapting new compounds (large/small molecules, peptides and stem cells), identifying invasive and non-invasive (imaging) biomarkers and selecting lead compounds for regulatory submission (n= 15) in anemia, autoimmune (RA and IBD), diabetes, NASH, chronic/diabetic renal failure and immunotherapy therapeutic areas.
Subba holds a Ph.D. from Case Western Reserve University and earned his MBA from the Kelly School of Business at Indiana University